Markets

News Details

( 03 Nov 2020)
Sun Pharma. - Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2020

The Board of Directors of the Company at its meeting held today i.e. November 03, 2020 has inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2020.

Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we enclose herewith the following as 'Annexure':

a) Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2020.

b) Limited Review Report of the Statutory Auditors of the Company on Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2020.

The meeting of the Board of Directors of the Company commenced at 10:30 a.m. and concluded at 02:40 p.m.